Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease (Q36838665)

From Wikidata

Jump to navigation Jump to search

scientific article published on June 2007

Language	Label	Description	Also known as
English	Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease	scientific article published on June 2007

Statements

scholarly article

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease (English)

1 reference

Europe PubMed Central

16 August 2017

0 references

diabetic nephropathy

1 reference

based on heuristic

inferred from title

author name string

Takahiko Nakagawa

1

1 reference

Europe PubMed Central

16 August 2017

publication date

1 June 2007

1 reference

Europe PubMed Central

16 August 2017

American Journal of Physiology - Renal Physiology

1 reference

Europe PubMed Central

16 August 2017

292

1 reference

Europe PubMed Central

16 August 2017

F1665-72

1 reference

Europe PubMed Central

16 August 2017

6

1 reference

Europe PubMed Central

16 August 2017

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Enhanced antiproliferative effect of nitric oxide in cultured smooth muscle cells from diabetic rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Angiotensin II stimulation of VEGF mRNA translation requires production of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Endothelial dysfunction as a modifier of angiogenic response in Zucker diabetic fat rat: amelioration with Ebselen

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Lack of endothelial nitric oxide synthase aggravates murine accelerated anti-glomerular basement membrane glomerulonephritis

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

The ICAM-1/LFA-1 interaction in glomerular leukocytic accumulation in anti-GBM glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Nitric oxide modulates vascular disease in the remnant kidney model

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Hyperuricemia induces endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Role of microvascular rarefaction in the increased arterial pressure in mice lacking for the endothelial nitric oxide synthase gene (eNOS3pt-/- ).

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Cyclosporin A inhibits flow-mediated activation of endothelial nitric-oxide synthase by altering cholesterol content in caveolae

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Abnormal metabolic fate of nitric oxide in Type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Mesangiolysis: an update

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Uncoupling of vascular endothelial growth factor with nitric oxide as a mechanism for diabetic vasculopathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

VEGF(165) mediates glomerular endothelial repair

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

On glomerular structural alterations in type-1 diabetes. Companions of early diabetic glomerulopathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Development of renal structural lesions in type-1 diabetic patients with microalbuminuria. Observations by light microscopy in 8-year follow-up biopsies.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

New vessel formation in the renal corpuscles in advanced diabetic glomerulopathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Mesangiolysis in diabetic glomeruli: its role in the formation of nodular lesions

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Endogenous NO blockade enhances tissue factor expression via increased Ca2+ influx through MCP-1 in endothelial cells by monocyte adhesion.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

The role of vascular endothelial growth factor (VEGF) in renal pathophysiology

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Reciprocal relation between VEGF and NO in the regulation of endothelial integrity

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Nitric oxide inhibition enhances platelet aggregation in experimental anti-Thy-1 nephritis

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00495.2006

21 January 2018

Identifiers

10.1152/AJPRENAL.00495.2006

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36838665&oldid=1660070992"